Debate: Should we waive COVID-19 vaccine patents for low-income countries? | Pro/Con
The world needs to get more doses into the arms of people in the developing world, but are patent waivers the best way to go about it?
Skip to contentA bag of empty vials of the Pfizer-BioNTech COVID-19 vaccine.